High Frequency Oscillations in Neurologic Disease
Chronically-recorded Deep Brain Nuclei/Hippocampal High Frequency Oscillations (HFOs) as Biomarkers of Neurologic Disease.
Sponsor: Mayo Clinic
This PHASE1 trial investigates Epilepsy and Parkinson and is currently completed. Mayo Clinic leads this study, which shows 12 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
May 2022 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
May 2021 — May 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Dec 2019 — Jul 2020 [monthly]
Active Not Recruiting PHASE1
-
Sep 2018 — Dec 2019 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .